On Friday, Shares of Rite Aid Corporation (NYSE:RAD), lost -2.63% to $8.88.
Rite Aid Corporation has declared that Ken Martindale, who is presently president and chief operating officer, has been promoted to the newly created position of CEO of Rite Aid stores, effective right away. Martindale, 55, will continue to report to John Standley, Rite Aid’s chairman and CEO, and will retain his role as president of Rite Aid Corporation.
Frank Sheehy, the CEO of EnvisionRx and Web Golinkin, the CEO of RediClinic and Health Dialog, will report to Standley.
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Shares of Visa Inc. (NYSE:V), inclined 0.86% to $74.21, during its last trading session.
Visa declared a partnership with AirPay Co. Ltd. (AirPay), a fast-growing payment network provider in Southeast Asia. This agreement will allow AirPay to provide secure mobile payment services to Garena users, in addition to support the company grow its market share in the region.
AirPay ranks payment security and customer experience among its top business priorities as it focuses on extending its mobile payment services to merchants. AirPay aims to provide mobile payment services to 14 million active, monthly mobile users of Garena, an Internet company. These mobile payment services enable Garena’s mobile users to conveniently and securely pay for online games, telephone bills, utilities and eCommerce transactions.
Through this partnership, AirPay will adopt CyberSource’s fraud administration tool, Decision Manager, in addition to its payment tokenization solution. Together, these solutions will enable Garena users to make payments on their mobile and tablet devices, securely and efficiently, with a wide spectrum of major credit cards.
Visa Inc., a payments technology company, operates as a retail electronic payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Finally, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), ended its last trade with -13.31% loss, and closed at $39.14.
ACADIA Pharmaceuticals declared its unaudited financial results for the second quarter ended June 30, 2015.
Research and development expenses raised to $18.4 million for the second quarter of 2015, counting $2.8 million in stock-based compensation expense, from $13.8 million for the comparable quarter of 2014, counting $1.1 million in stock-based compensation expense. This enhance was primarily due to an enhance of $4.1 million in personnel and related costs and stock-based compensation expense associated with ACADIA’s expanded research and development organization.
General and administrative expenses raised to $21.1 million for the second quarter of 2015, counting $4.7 million in stock-based compensation expense, from $8.0 million for the comparable quarter of 2014, counting $3.2 million in stock-based compensation expense. This enhance was due to enhances in personnel and related costs of $7.9 million and enhances in external services costs of $5.2 million, all largely related to ACADIA’s commercial preparations for the planned launch of NUPLAZID.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.